Incidence of papillary microcarcinoma in patients operated on thyroid cancer

Authors

Keywords:

PROGNOSIS, BIOPSY, FINE-NEEDLE, THYROIDECTOMY

Abstract

Introduction: although papillary thyroid microcarcinoma has suffered an increase in incidence in the last decades, the extension of gland resection and oncological treatment is still a controversy.

Objective: to determine the incidence of papillary thyroid microcarcinoma in patients who have undergone surgery for thyroid cancer at Leon Cuervo Rubio Hospital in Pinar del Río, 2018-2020.

Methods: a descriptive and cross-sectional study of 22 patients operated for thyroid microcarcinoma was carried out, who underwent a total thyroidectomy, collecting data from the clinical histories, surgery reports and biopsies. Observation and analysis approaches were used.

Variables to be analyzed: size of the tumor, BAAF results, definitive diagnosis, histological variety, associated thyroid diseases and extension of the disease

Results: the 22 patients operated on thyroid microcarcinoma represented 42.30% of the total number of cases operated for cancer reasons. Female sex predominated and average age is 49.9 years; 31.81% of the patients with biopsy correspond to the Bethesda I, II and III group, however they were carriers of microcarcinoma; 18% of the patients were carriers of two histological varieties of carcinoma.

Conclusions: papillary thyroid microcarcinoma continues the increase of its incidence, especially in patients over 45 years old, with extension beyond the gland, which aggravates the prognosis of the patient suffering from it and requires multidisciplinary medical care to determine prognostic risk factors and to improve the behavior to be followed and the quality of life of the patient.

Downloads

Download data is not yet available.

Author Biographies

Gladys Iglesias Díaz, Universidad de Ciencias Médicas de Pinar del Río. Hospital Clínico Quirúrgico León Cuervo Rubio. Pinar del Río, Cuba

profesora auxiliar,espec,segundo grado MCs en longevidad satisfactoria , esp,cirugía ahora de misión en LAOS

Juan Carlos Bravo Díaz, Banco de sangre de Matanzas

Especialista de primer grado de medicina general e integral.Profesor asistente

Ivan García García, Universidad de Ciencias Médicas de Pinar del Río. Hospital Clínico Quirúrgico León Cuervo Rubio. Pinar del Río, Cuba

Especialista de primer grado de medicina general e integral y de cirugía general. Profesor asistente

Eduardo Enrrique Cecilia Paredes, Facultad de Ciencias Médicas de Pinar de Río

Estudiante de quinto año de la Carrera de medicina

References

1. Fernández VL. Caracterización clínico- molecular de los carcinomas de tiroides [Internet]. Universidad de Oviedo; 2016 [citado 20/05/2020]. Disponible en: https://digibuo.uniovi.es/dspace/bitstream/handle/10651/39121/Fernandez%20Va%20%F1es.pdf;jsessionid=D940C2A492D848C210A90537917A347F?sequence=3

2. Galindo CH. Microcarcinoma papilar de tiroides [Internet]. Universidad de Cantabria; Santander, junio 2016 [citado 20/05/2020]. Disponible en: https://repositorio.unican.es/xmlui/bitstream/handle/10902/8774/HierroGalindoC.pdf?sequence=4

3. Makay Ö, Özdemir M, Şenyürek YG, Tunca F, Düren M, Uludağ M, et al. Surgical approaches for papillary microcarcinomas: Turkey’s perspective. Turk J Surg [Internet]. 2018 [citado 20/05/2020]; 34(2): 89-93. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30023969/

4. Mijares Briñez A, León A. Suarez CM, Bracamontes A. Factores predictivos y de riesgo en el microcarcinoma papilar tiroideo. Rev. Venez. de Oncología [Internet]. 2019 [citado 20/05/2020]; 31(4). Disponible en: https://www.redalyc.org/jatsRepo/3756/375659943005/html/index.html

5. Rodríguez H, Pava R, Castaño LF, Valencia LV, Pava A. Evaluación de la precisión diagnóstica de la punción aspiración con aguja fina en pacientes con nódulo tiroideo. Revista Biosalud [Internet]. 2017 [citado 20/05/2020]; 16(1): 11-18. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-888560

6. Ramírez Núñez E, Moró Vela RÁ. Eficiencia de la punción por aspiración con aguja fina en el diagnóstico de las afecciones del tiroides. Rev. inf. cient [Internet]. 2019 Oct [citado 09/11/2020]; 98(5): 577-586. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1028-99332019000500577&lng=es

7. Perrotta F, Brizuela J, García L, Ortiz P, Arévalo A. Metástasis ósea como primera manifestación de carcinoma diferencial de tiroides. Reporte de Caso. Rev.Cir. Prag [Internet]. 2020 [citado 09/11/2020]; 44(1). Disponible en: http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S2307-04202020000100030&lng=en&nrm=iso&tlng=es

8. Schmidt A, Cross G, Pitoia F. Metástasis a distancia en cáncer diferenciado de tiroides: diagnóstico y tratamiento. Rev Argent Endocrinol Metab. [Internet]. 2017 [citado 09/11/2020]; 54(2):92-100. Disponible en: https://www.elsevier.es/es-revista-revista-argentina-endocrinologia-metabolismo-185-articulo-metastasis-distancia-cancer-diferenciado-tiroides-S0326461017300074

9. Olmos R, López J, Donoso F, Ruiz-Esquide M. Manejo de nódulos tiroideos y cáncer de tiroides con lobectomía: experiencia de un equipo multidisciplinario. Rev Chil Endo Diab [Internet]. 2020 [citado 09/11/2020]; 13(3): 118-124. Disponible en: http://www.revistasoched.cl/3_2020/6.pdf

10. Corrales Hernández JJ, Martín Iglesias D, Gómez Alfonso FJ. Microcarcinoma papilar de tiroides. ¿Es necesario el tratamiento con 131 I tras la cirugía? ¿Argumentos a favor? Rev. End. Nutr [Internet]. 2006 [citado 09/11/2020]; 53(6): 390-8. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1575092206711214

11. Ruiz Pardo J, Zambudio Ríos A, Rodríguez Gonzales JM, Paredes Quiles M. Microcarcinoma papilar de tiroides con extensión extratiroidea mínima. ¿Tiene un curso tan indolente para precisar un tratamiento menos intensivo?. Rev.clin española [Internet]. 2020 [citado 09/11/2020]. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0014256520300606

12. Zheng W, Wang K, Wu J, Wang W, Shang J. Multifocality is associated with central neck lymph node metastases in papillary thyroid microcarcinoma. Cancer Manag Res [Internet]. 2018 [citado 09/11/2020]; 10:1527-1533. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29942154/

13. Apel R, Asa S, LiVolsi V. Papillary Hürthle cell carcinoma with lymphocytic stroma. “Warthin-like tumor” of the thyroid. Am J Surg Pathol [Internet]. 1995 [citado 09/11/2020]; 19(7): 810-814. Disponible en: https://pubmed.ncbi.nlm.nih.gov/7793479/

14. Wang F, Yu X, Shen X, Zhu G, Huang Y, Liu R, et al. The prognostic value of tumor multifocality in clinicaloutcomes of papillary thyroid cancer. J Clin Endocrinol Metab [Internet]. 2017 [citado 09/11/2020]; 102(9): 3241-3250. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28582521/

15.Grant Tate M M, Rodríguez Marzo I, Guerra Macías Il, Neyra Barros R, Zayas Simón OP. Caracterización clínica, patológica y epidemiológica de pacientes con carcinoma diferenciado de tiroides. MEDISAN [Internet]. 2019 Ago [citado 09/11/2020]; 23(4): 692-701. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192019000400692&lng=es

16. Salman Mardones P. Carcinoma tiroideo papilar oncocítico variante “Warthin-like tumor”. Caso clínico y revisión de la literatura. Rev.Chil.End. diabetes [Internet]. 2013 [citado 09/11/2020]; 6(4): 140-142. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/lil-780400?lang=es

Downloads

Published

2021-02-04

How to Cite

1.
Díaz GI, Bravo Díaz JC, García García I, Cecilia Paredes EE. Incidence of papillary microcarcinoma in patients operated on thyroid cancer. Rev Ciencias Médicas [Internet]. 2021 Feb. 4 [cited 2025 Oct. 12];25(1):e4745. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/4745

Issue

Vol. 25 No. 1 (2021)

Section

ORIGINAL ARTICLES

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/